Informations techniques
Exploitant
UCB PHARMA S.A.
Présentation
RYSTIGGO 140 mg/mL, solution injectable par voie sous-cutanée
1 flacon en verre de 2 ml (CIP : 34009 302 847 4 2)
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
gfQkUPufMTGjYLSU